RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
We appreciate the letter from Marjan Attaei and Salim Yusuf in which they express concern that the cost estimates for treating hypertension cited by the Lancet Commission on Hypertension1 might be misleading because it is unclear whether the figures cited by the Commission represent cost per capita or cost per patient treated, and because subsequent data collected by Attaei and Yusuf indicate that cost per patient treated might be higher than that quoted by the Commission.